Europe Cyclodextrin Market Size, Share & Trends Analysis Report By Type (Beta-Cyclodextrin, Alpha-Cyclodextrin, and Gamma-Cyclodextrin), By End-use, By Country and Growth Forecast, 2024 - 2031

Europe Cyclodextrin Market Size, Share & Trends Analysis Report By Type (Beta-Cyclodextrin, Alpha-Cyclodextrin, and Gamma-Cyclodextrin), By End-use, By Country and Growth Forecast, 2024 - 2031


The Europe Cyclodextrin Market would witness market growth of 5.4% CAGR during the forecast period (2024-2031). In the year 2021, the Europe market's volume surged to 165.67 Tonnes, showcasing a growth of 17.6% (2020-2023).

Alpha-cyclodextrin, a type of cyclodextrin, plays a crucial role in the market across various industries. In pharmaceutical applications, pharmaceutical grade this serves as a solubilizing agent, enhancing the aqueous solubility of poorly water-soluble drugs. This property is pivotal in drug development, as it improves the bioavailability and therapeutic efficacy of medications. Therefore, the demand of this product in Germany was 3.50 Tonnes in 2023.

The Germany market dominated the Europe Cyclodextrin Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $30,374.9 Thousands by 2031. The UK market exhibits a CAGR of 5.1% during (2024 - 2031). Additionally, The France market would experience a CAGR of 5.8% during (2024 - 2031).

In the food industry, cyclodextrins serve as encapsulating agents for flavour compounds, fragrances, and sensitive ingredients such as vitamins and antioxidants. These helps preserve their integrity, extend shelf life, and prevent flavour degradation by encapsulating these volatile or sensitive compounds. They also contribute to flavour modulation and texture enhancement in various food products, including beverages, confectionery, and baked goods.

Cyclodextrins are crucial in cosmetics and personal care products by improving active ingredients’ stability, solubility, and skin penetration. They are used in skincare formulations to encapsulate antioxidants, moisturizers, and UV filters, enhancing their efficacy and prolonging their activity on the skin. These also contribute to developing encapsulated delivery systems for targeted skincare applications, such as anti-aging and skin brightening.

With the expansion of the pharmaceutical industry in Belgium, there will likely be a surge in the demand for this product as pharmaceutical excipients. Belgian pharmaceutical companies may increasingly utilize this in drug formulations to enhance solubility, stability, and bioavailability, driving local demand for these products. In conclusion, the increasing cosmetics and pharmaceutical industries are driving the market’s growth.

Based on Type, the market is segmented into Beta-Cyclodextrin, Alpha-Cyclodextrin, and Gamma-Cyclodextrin. Based on End-use, the market is segmented into Pharmaceutical, Food, Cosmetics & Personal Care, Chemical, Textile and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled
  • Midas Pharma Gmbh
  • Wacker Chemie AG
  • Roquette Freres SA
  • Cambrex Corporation
  • Wellona Pharma
  • Cayman Chemical Company, Inc.
  • Cyclolab Kft.
  • Ligand Pharmaceuticals Incorporated
  • Tocopharm Co. Limited
  • Merck KGaA
Europe Cyclodextrin Market Report Segmentation

By Type (Volume, Tonnes, USD Million, 2020-2031)
  • Beta-Cyclodextrin
  • Alpha-Cyclodextrin
  • Gamma-Cyclodextrin
By End-use (Volume, Tonnes, USD Million, 2020-2031)
  • Pharmaceutical
  • Food
  • Cosmetics & Personal Care
  • Chemical
  • Textile
  • Others
By Country (Volume, Tonnes, USD Million, 2020-2031)
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cyclodextrin Market, by Type
1.4.2 Europe Cyclodextrin Market, by End-use
1.4.3 Europe Cyclodextrin Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Europe Cyclodextrin Market by Type
4.1 Europe Beta-Cyclodextrin Market by Country
4.2 Europe Alpha-Cyclodextrin Market by Country
4.3 Europe Gamma-Cyclodextrin Market by Country
Chapter 5. Europe Cyclodextrin Market by End-use
5.1 Europe Pharmaceutical Market by Country
5.2 Europe Food Market by Country
5.3 Europe Cosmetics & Personal Care Market by Country
5.4 Europe Chemical Market by Country
5.5 Europe Textile Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Cyclodextrin Market by Country
6.1 Germany Cyclodextrin Market
6.1.1 Germany Cyclodextrin Market by Type
6.1.2 Germany Cyclodextrin Market by End-use
6.2 UK Cyclodextrin Market
6.2.1 UK Cyclodextrin Market by Type
6.2.2 UK Cyclodextrin Market by End-use
6.3 France Cyclodextrin Market
6.3.1 France Cyclodextrin Market by Type
6.3.2 France Cyclodextrin Market by End-use
6.4 Russia Cyclodextrin Market
6.4.1 Russia Cyclodextrin Market by Type
6.4.2 Russia Cyclodextrin Market by End-use
6.5 Spain Cyclodextrin Market
6.5.1 Spain Cyclodextrin Market by Type
6.5.2 Spain Cyclodextrin Market by End-use
6.6 Italy Cyclodextrin Market
6.6.1 Italy Cyclodextrin Market by Type
6.6.2 Italy Cyclodextrin Market by End-use
6.7 Rest of Europe Cyclodextrin Market
6.7.1 Rest of Europe Cyclodextrin Market by Type
6.7.2 Rest of Europe Cyclodextrin Market by End-use
Chapter 7. Company Profiles
7.1 Midas Pharma GmbH
7.1.1 Company Overview
7.2 Wacker Chemie AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 Roquette Freres SA
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.3.3 SWOT Analysis
7.4 Cambrex Corporation
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 Wellona Pharma
7.5.1 Company Overview
7.6 Cayman Chemical Company, Inc.
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 Cyclolab Kft.
7.7.1 Company Overview
7.8 Ligand Pharmaceuticals Incorporated
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Research & Development Expenses
7.9 Tocopharm Co. Limited
7.9.1 Company Overview
7.10. Merck KGaA
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings